Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

The Invitrogen Collibri DNA Library Prep Kits prepare libraries for whole-genome sequencing (WGS) on Illumina NGS systems and contain tracking dyes to quickly and easily visualize library prep ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

“Illumina’s newest distributable IVD kit for comprehensive genomic profiling ... and deletions from DNA, and fusions in 24 genes and splice variants in one gene from RNA. The test also reports a Tumor ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Through comprehensive DNA exploration ... oncology testing, infectious disease testing and surveillance. Genomic surveillance is essential in fighting the pandemic. Illumina is pleased to partner ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies ... a cutting-edge software upgrade and new kits.

China accounts for about 7% of Illumina's sales. Gene sequencers help determine the sequence of DNA or RNA, allowing scientists to study genetic variations associated with diseases and diagnose ...